Company
Sotera Health Company
Headquarters: Broadview Heights, OH, United States
Employees: 3,000
CEO: Mr. Michael B. Petras Jr.
Market Cap
$3.33 Billion
USD as of July 1, 2025
Sotera Health Company Categories
United States Healthcare Diagnostics & ResearchUnited States Healthcare United States Diagnostics & Research
Top Competitors by Market Capitalization
Industry: Diagnostics & Research
| Company | Market Cap (USD) |
|---|---|
| Thermo Fisher Scientific | $162.07 B |
| Danaher | $144.92 B |
| Siemens Healthineers AG | $64.17 B |
| Lonza Group Ltd | $49.67 B |
| IDEXX Laboratories, Inc. | $43.99 B |
Sector:
| Company | Market Cap (USD) |
|---|---|
| Lilly | $699.59 B |
| Johnson & Johnson | $374.29 B |
| AbbVie | $336.94 B |
| Novo Nordisk | $309.91 B |
| UnitedHealth Group | $279.90 B |
Detailed Description
Sotera Health Company provides sterilization, and lab testing and advisory services to the medical device, pharmaceutical, and food products industries in the Americas, Europe and Asia. The company's sterilization services include gamma and electron beam irradiation, and EO processing; Nelson Labs comprise microbiological and analytical chemistry testing; and advisory services for medical device and biopharmaceutical industries. It serves medical devices; pharmaceuticals; food and agricultural products; and commercial, advanced, and specialty application industries. The company was formerly known as Sotera Health Topco, Inc. and changed its name to Sotera Health Company in October 2020. Sotera Health Company was incorporated in 2017 and is headquartered in Broadview Heights, Ohio.
Financials
| Last Financial Reports Date | March 31, 2025 |
| Revenue TTM | $1.11 B |
| EBITDA | $471.3 M |
| Gross Profit TTM | $610.6 M |
| Profit Margin | 2.24% |
| Operating Margin | 27.86% |
| Quarterly Revenue Growth | 2.60% |
Stocks & Indices
Sotera Health Company has the following listings and related stock indices.
Stock: NASDAQ: SHC wb_incandescent
Stock: Munich: SH5 wb_incandescent